Safety analysis of all active risk evaluation & mitigation strategy for U.S. FDA approved drugs - An Indian perspective

Indian J Med Res. 2024 Jun;159(6):581-584. doi: 10.25259/ijmr_350_22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Approval*
  • Humans
  • India / epidemiology
  • Risk Evaluation and Mitigation
  • United States / epidemiology
  • United States Food and Drug Administration*